FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

John Hiemenz

Research Profile

Disorders

Chemicals & Drugs

Procedures

Concepts & Ideas

Retrospective Studies

Co-author Network

Publications

TOP 3
John R Wingard; John W Hiemenz; Michael A Jantz
How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation.
John R Wingard; Jack Hsu; John W Hiemenz
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
John R Wingard; Jack Hsu; John W Hiemenz
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of John Hiemenz (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: John R Wingard; John W Hiemenz; Michael A Jantz
How I manage pulmonary nodular lesions and nodular infiltrates in patients with hematologic malignancies or undergoing hematopoietic cell transplantation.
Blood 2012;120(9):1791-800.
2011: John R Wingard; Jack Hsu; John W Hiemenz
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Hematology/oncology clinics of North America 2011;25(1):101-16.
2010: John R Wingard; Jack Hsu; John W Hiemenz
Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology.
Infectious disease clinics of North America 2010;24(2):257-72.
2009: John W Hiemenz
Management of infections complicating allogeneic hematopoietic stem cell transplantation.
Seminars in hematology 2009;46(3):289-312.
2004: Jo-Anne H van Burik; Voravit Ratanatharathorn; Daniel E Stepan; Carole B Miller; Jeffrey H Lipton; David H Vesole; Nancy Bunin; Donna A Wall; John W Hiemenz; Yoichi Satoi; Jeanette M Lee; THOMAS WALSH
Micafungin versus fluconazole for prophylaxis against invasive fungal infections during neutropenia in patients undergoing hematopoietic stem cell transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004;39(10):1407-16.
2004: THOMAS WALSH; A Groll; John W Hiemenz; R Fleming; Emmanuel Roilides; E Anaissie
Infections due to emerging and uncommon medically important fungal pathogens.
Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases 2004;10 Suppl 1():48-66.
2003: John W Hiemenz
Amphotericin B deoxycholate administered by continuous infusion: does the dosage make a difference?
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2003;36(8):952-3.
2001: John R Perfect; G M Cox; J Y Lee; Carol A Kauffman; L de Repentigny; Stanley W Chapman; V A Morrison; Paul Pappas; John W Hiemenz; David A Stevens
The impact of culture isolation of Aspergillus species: a hospital-based survey of aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(11):1824-33.
2001: John H Rex; THOMAS WALSH; Mary D Nettleman; Elias J Anaissie; JOHN BENNETT; E J Bow; A J Carillo-Munoz; Pascal Chavanet; Gretchen A Cloud; D W Denning; B E de Pauw; J E Edwards Jr; John W Hiemenz; Carol A Kauffman; G Lopez-Berestein; P Martino; Jack D Sobel; David A Stevens; R Sylvester; J Tollemar; C Viscoli; M A Viviani; T Wu
Need for alternative trial designs and evaluation strategies for therapeutic studies of invasive mycoses.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2001;33(1):95-106.
1999: John R Wingard; P Kubilis; L Lee; G Yee; M White; L Walshe; R Bowden; E Anaissie; John W Hiemenz; J Lister
Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1999;29(6):1402-7.
1999: THOMAS WALSH; Nita L Seibel; Carola Arndt; R E Harris; M J Dinubile; Annette C Reboli; John W Hiemenz; STEPHEN CHANOCK
Amphotericin B lipid complex in pediatric patients with invasive fungal infections.
The Pediatric infectious disease journal 1999;18(8):702-8.
1999: Alison G Freifeld; Donna Marchigiani; THOMAS WALSH; STEPHEN CHANOCK; L Lewis; John W Hiemenz; S Hiemenz; J E Hicks; Vee J Gill; Seth M Steinberg; PA Pizzo
A double-blind comparison of empirical oral and intravenous antibiotic therapy for low-risk febrile patients with neutropenia during cancer chemotherapy.
The New England journal of medicine 1999;341(5):305-11.
1999: THOMAS WALSH; R W Finberg; Carola Arndt; John W Hiemenz; C Schwartz; D Bodensteiner; Peter Pappas; Nita L Seibel; R N Greenberg; S Dummer; M Schuster; John Holcenberg
Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group.
The New England journal of medicine 1999;340(10):764-71.
1998: THOMAS WALSH; John W Hiemenz; Nita L Seibel; John R Perfect; G Horwith; L Lee; J L Silber; M J DiNubile; Annette C Reboli; E Bow; J Lister; Elias J Anaissie
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1998;26(6):1383-96.
1997: Jo-Anne H van Burik; Robert C Hackman; S Q Nadeem; John W Hiemenz; Mary H White; Mary E D Flowers; Raleigh A Bowden
Nocardiosis after bone marrow transplantation: a retrospective study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(6):1154-60.
1997: Mary H White; Elias J Anaissie; S Kusne; John R Wingard; John W Hiemenz; A Cantor; Marc Gurwith; C Du Mond; RD Mamelok; Raleigh A Bowden
Amphotericin B colloidal dispersion vs. amphotericin B as therapy for invasive aspergillosis.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1997;24(4):635-42.
1996: THOMAS WALSH; John W Hiemenz; E Anaissie
Recent progress and current problems in treatment of invasive fungal infections in neutropenic patients.
Infectious disease clinics of North America 1996;10(2):365-400.
1990: M J Browne; D Potter; J Gress; Deborah Cotton; John W Hiemenz; M Thaler; J Hathorn; Steven Brower; Vee J Gill; E Glatstein
A randomized trial of open lung biopsy versus empiric antimicrobial therapy in cancer patients with diffuse pulmonary infiltrates.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(2):222-9.
1986: PA Pizzo; J W Hathorn; John W Hiemenz; M Browne; J Commers; Deborah Cotton; J Gress; Dan Longo; D Marshall; J McKnight
A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia.
The New England journal of medicine 1986;315(9):552-8.
1986: John W Hiemenz; J Skelton; PA Pizzo
Perspective on the management of catheter-related infections in cancer patients.
Pediatric infectious disease 1986;5(1):6-11.
1985: PA Pizzo; M Thaler; J Hathorn; John W Hiemenz; J Skelton; J McKnight; M Rubin; M Browne; Dan Longo; Deborah Cotton
New beta-lactam antibiotics in granulocytopenic patients. New options and new questions.
The American journal of medicine 1985;79(2A):75-82.
1984: PA Pizzo; J Commers; D Cotton; J Gress; J Hathorn; John W Hiemenz; Dan Longo; D Marshall; K J Robichaud
Approaching the controversies in antibacterial management of cancer patients.
The American journal of medicine 1984;76(3):436-49.